Hledání článků
Filtry
Warnock DG, Ortiz A, Mauer M, et al. Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant 2012;27:1042–1049.
Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil‑Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group. Sirolimus and secondary skin‑cancer prevention in kidney transplantation. N Engl J Med 2012;367:329–339.
Harris TJ, Nazir R, Khetpal R, et al. Pain, sleep disturbances and survival in hemodialysis patients. Nephrol Dial Transplant 2012;27:758–765.
. KDIGO Clinical Practice Guideline for glomerulonephritis. Kidney Int 2012;2(Suppl):139–274.
Kim JK, Kim JH, Lee SC, et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol 2012;7:427–436.
Johns BR, Pao AC, Kim SH. Metabolic syndrome, insulin resistence and kidney function in non‑diabetic individuals. Nephrol Dial Transpl 2012; 27:1410–1415.
Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ; for the CONTRAST Investigators. Effect of online hemodiafiltration on all‑cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23:1087–1096.
Locatelli F et al. Predictors of haemoglobin levels and resistance to erythropoiesis‑stimulating agents in patients treated with low‑flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. Nephrol Dial Transplant; first published online May 23, 2012 doi:10.1093/ndt/gfs117
Yilmaz MI, Sonmez A, Saglam M, et al. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis 2012;59:177–185.
Budde K, Lehner F, Sommerer C, Arns W, Reinke P, Eisenberger U, Wüthrich RP, Scheidl S, May C, Paulus EM, Mühlfeld A, Wolters HH, Pressmar K, Stahl R, Witzke O; on behalf of the ZEUS study investigators. Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3‑year results from the randomized ZEUS study. Am J Transplant 2012;12:1528–1540.
Peters AM, Perry L, Hooker C, et al. Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effect of age, gender, obesity and scaling. Nephrol Dial Transpl 2012;27:1429–1437.
Ostermann M, Dickie H, Barrett NA. Renal replacement therapy in critically ill patients with acute kidney injury – when to start. Nephrol Dial Transplant 2012 (e‑pub ahead of print).
Gross O, Licht C, Anders HJ, et al. Early angiotensin‑converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 2012;81:494–501.